非酒精性脂肪性肝病的血清学诊断研究进展
Research Advances in the Serological Diagnosis of Non-Alcoholic Fatty Liver Disease
DOI: 10.12677/acm.2025.151166, PDF,   
作者: 赵苏仁格格, 邵欣东：内蒙古医科大学通辽临床医学院，内蒙古 通辽；敖文静：通辽市人民医院消化内镜中心，内蒙古 通辽；庞慧芳*：内蒙古医科大学通辽临床医学院，内蒙古 通辽；通辽市人民医院消化内镜中心，内蒙古 通辽
关键词: 非酒精性脂肪性肝病；血清生物标志物；血清学指标；无创诊断；Non-Alcoholic Fatty Liver Disease； Serum Biomarkers； Serologic Indicators； Non-Invasive Diagnosis
摘要: 非酒精性脂肪性肝病(NAFLD)已成为全球最普遍的慢性肝病，不仅增加肝硬化和肝癌风险，还与心血管疾病等并发症有关联，对患者健康和经济造成重大负担。因此，NAFLD的早期诊断和干预至关重要，以防疾病恶化。本文探讨了血清学指标在NAFLD非侵入性诊断中的应用，旨在提高诊断的准确性和病情监测，以期更好地了解和管理NAFLD。
Abstract: Non-alcoholic fatty liver disease (NAFLD) has become the most common chronic liver disease worldwide. In addition to increasing the risk of cirrhosis and liver cancer, NAFLD is also associated with cardiovascular disease, which is a significant health and economic burden for patients. Therefore, early diagnosis and intervention of NAFLD are crucial to prevent disease progression. In this paper, we discuss the application of serological indicators in the non-invasive diagnosis of NAFLD with the aim of improving the accuracy of diagnosis and monitoring of the disease and providing a scientific basis for the management and understanding of NAFLD.
文章引用：赵苏仁格格, 邵欣东, 敖文静, 庞慧芳. 非酒精性脂肪性肝病的血清学诊断研究进展[J]. 临床医学进展, 2025, 15(1): 1250-1255. https://doi.org/10.12677/acm.2025.151166

参考文献

[1] Buzzetti, E., Pinzani, M. and Tsochatzis, E.A. (2016) The Multiple-Hit Pathogenesis of Non-Alcoholic Fatty Liver Disease (NAFLD). Metabolism, 65, 1038-1048. [Google Scholar] [CrossRef] [PubMed]
[2] 范建高, 徐小元, 南月敏, 等. 代谢相关(非酒精性)脂肪性肝病防治指南(2024年版) [J]. 实用肝脏病杂志, 2024, 27(4): 494-510.
[3] de Alteriis, G., Pugliese, G., Di Sarno, A., Muscogiuri, G., Barrea, L., Cossiga, V., et al. (2023) Visceral Obesity and Cytokeratin-18 Antigens as Early Biomarkers of Liver Damage. International Journal of Molecular Sciences, 24, Article No. 10885. [Google Scholar] [CrossRef] [PubMed]
[4] Chuah, K., Wan Yusoff, W.N.I., Sthaneshwar, P., Nik Mustapha, N.R., Mahadeva, S. and Chan, W. (2019) MACK‐3 (Combination of Homa, Ast and CK18): A Promising Novel Biomarker for Fibrotic Non‐Alcoholic Steatohepatitis. Liver International, 39, 1315-1324. [Google Scholar] [CrossRef] [PubMed]
[5] Huang, J., Yeh, M., Huang, C., Huang, C., Tsai, P., Tai, C., et al. (2017) PLOS ONE, 12, e0174394. [Google Scholar] [CrossRef] [PubMed]
[6] 李江佩, 孙音, 孔祥波, 等. 2型糖尿病合并非酒精性脂肪性肝病患者血清细胞角蛋白-18片段M30、脂联素和视黄醇结合蛋白4水平的变化及临床意义[J]. 临床和实验医学杂志, 2022, 21(9): 941-945.
[7] Zheng, K.I., Liu, W., Pan, X., Ma, H., Zhu, P., Wu, X., et al. (2020) Combined and Sequential Non-Invasive Approach to Diagnosing Non-Alcoholic Steatohepatitis in Patients with Non-Alcoholic Fatty Liver Disease and Persistently Normal Alanine Aminotransferase Levels. BMJ Open Diabetes Research & Care, 8, e001174. [Google Scholar] [CrossRef] [PubMed]
[8] Duan, Y., Pan, X., Luo, J., Xiao, X., Li, J., Bestman, P.L., et al. (2022) Association of Inflammatory Cytokines with Non-Alcoholic Fatty Liver Disease. Frontiers in Immunology, 13, Article ID: 880298. [Google Scholar] [CrossRef] [PubMed]
[9] 寿岚, 施军平, 张秋玲, 等. 非酒精性脂肪肝患者尿酸、25-羟基维生素D和肿瘤坏死因子的检测及临床意义[J]. 中国卫生检验杂志, 2019, 29(20): 2491-2493+2497.
[10] Polyzos, S.A., Aronis, K.N., Kountouras, J., Raptis, D.D., Vasiloglou, M.F. and Mantzoros, C.S. (2015) Circulating Leptin in Non-Alcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. Diabetologia, 59, 30-43. [Google Scholar] [CrossRef] [PubMed]
[11] Guo, Z., Du, H., Guo, Y., Jin, Q., Liu, R., Yun, Z., et al. (2023) Association between Leptin and NAFLD: A Two-Sample Mendelian Randomization Study. European Journal of Medical Research, 28, Article No. 215. [Google Scholar] [CrossRef] [PubMed]
[12] Mavilia, M.G. and Wu, G.Y. (2021) Liver and Serum Adiponectin Levels in Non‐Alcoholic Fatty Liver Disease. Journal of Digestive Diseases, 22, 214-221. [Google Scholar] [CrossRef] [PubMed]
[13] He, L., Deng, L., Zhang, Q., Guo, J., Zhou, J., Song, W., et al. (2017) Diagnostic Value of CK-18, FGF-21, and Related Biomarker Panel in Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis. BioMed Research International, 2017, Article ID: 9729107. [Google Scholar] [CrossRef] [PubMed]
[14] 芈肖肖, 严健, 施军平. 成纤维细胞生长因子21类似物对非酒精性脂肪性肝病斑马鱼模型疾病指征的改善情况[J]. 中华肝脏病杂志, 2023, 31(7): 742-749.
[15] Charoenngam, N. and Holick, M.F. (2020) Immunologic Effects of Vitamin D on Human Health and Disease. Nutrients, 12, Article No. 2097. [Google Scholar] [CrossRef] [PubMed]
[16] 付丽坤, 崔红梅, 卢坤玲, 等. 血清25(OH)维生素D与非酒精性脂肪肝肝脏脂肪含量的相关性[J]. 南方医科大学学报, 2019, 39(9): 1118-1121.
[17] Lee, I., Park, E. and Cho, J. (2020) Association of Nonalcoholic Fatty Liver Disease with Serum Vitamin D Levels in Combination of Physical Fitness in Korean Older Adults. The Journal of Steroid Biochemistry and Molecular Biology, 198, Article ID: 105569. [Google Scholar] [CrossRef] [PubMed]
[18] Ha, Y., Hwang, S. and Rim, K. (2017) The Association between Vitamin D Insufficiency and Nonalcoholic Fatty Liver Disease: A Population-Based Study. Nutrients, 9, Article No. 806. [Google Scholar] [CrossRef] [PubMed]
[19] Zhang, Z., Burrows, K., Fuller, H., Speliotes, E.K., Abeysekera, K.W.M., Thorne, J.L., et al. (2023) Non-Alcoholic Fatty Liver Disease and Vitamin D in the UK Biobank: A Two-Sample Bidirectional Mendelian Randomisation Study. Nutrients, 15, Article No. 1442. [Google Scholar] [CrossRef] [PubMed]
[20] 匡哲, 张永潮, 郭慧丽, 等. 血清铁蛋白表达与非酒精性脂肪性肝病肝脏脂肪含量的关系及临床意义[J]. 解放军预防医学杂志, 2019, 37(6): 36-37.
[21] 曹宇萌, 张海燕, 刘立新. 非酒精性脂肪性肝病的病理改变与血清铁蛋白和血清铁含量变化关系的meta分析[J]. 临床荟萃, 2023, 38(3): 197.
[22] Zhang, C., Wang, P., Li, Y., Huang, C., Ni, W., Chen, Y., et al. (2018) Role of MicroRNAs in the Development of Hepatocellular Carcinoma in Nonalcoholic Fatty Liver Disease. The Anatomical Record, 302, 193-200. [Google Scholar] [CrossRef] [PubMed]
[23] Xin, S., Zhan, Q., Chen, X., Xu, J. and Yu, Y. (2020) Efficacy of Serum Mirna Test as a Non-Invasive Method to Diagnose Nonalcoholic Steatohepatitis: A Systematic Review and Meta-Analysis. BMC Gastroenterology, 20, Article No. 186. [Google Scholar] [CrossRef] [PubMed]
[24] Konings, M.C.J.M., Baumgartner, S., Mensink, R.P. and Plat, J. (2022) Investigating MicroRNAs to Explain the Link between Cholesterol Metabolism and NAFLD in Humans: A Systematic Review. Nutrients, 14, Article No. 4946. [Google Scholar] [CrossRef] [PubMed]
[25] Kryza, T., Khan, T., Lovell, S., Harrington, B.S., Yin, J., Porazinski, S., et al. (2021) Substrate-Biased Activity-Based Probes Identify Proteases That Cleave Receptor Cdcp1. Nature Chemical Biology, 17, 776-783. [Google Scholar] [CrossRef] [PubMed]
[26] Lovric, A., Granér, M., Bjornson, E., Arif, M., Benfeitas, R., Nyman, K., et al. (2018) Characterization of Different Fat Depots in NAFLD Using Inflammation-Associated Proteome, Lipidome and Metabolome. Scientific Reports, 8, Article No. 14200. [Google Scholar] [CrossRef] [PubMed]
[27] Jia, X., Song, E., Liu, Y., Chen, J., Wan, P., Hu, Y., et al. (2023) Identification and Multicentric Validation of Soluble CDCP1 as a Robust Serological Biomarker for Risk Stratification of NASH in Obese Chinese. Cell Reports Medicine, 4, Article ID: 101257. [Google Scholar] [CrossRef] [PubMed]

为你推荐